Interleukin-36 Promotes Systemic Type-I IFN Responses in Severe Forms of Psoriasis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.08.444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Experience With the Systemic Treatment of Severe Forms of Psoriasis

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2012English

Sialoadhesin Promotes Rapid Proinflammatory and Type I IFN Responses to a Sialylated Pathogen, Campylobacter Jejuni

Journal of Immunology
AllergyImmunology
2012English

IRF-7 Mediates Type I IFN Responses in Endotoxin-Challenged Mice

Frontiers in Immunology
AllergyImmunology
2020English

Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells

Journal of Immunology
AllergyImmunology
2018English

310 Unopposed IL-36 Activity Promotes Clonal CD4 + T-Cell Responses With IL-17A Production in Generalized Pustular Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Cyclooxygenase 2 Inhibition Promotes IFN- -Dependent Enhancement of Antitumor Responses

Journal of Immunology
AllergyImmunology
2005English

352 Commensal Microbiota Trigger Type I IFN-dependent Innate Wound Repair Responses in Injured Skin

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Macrophage IFN-I Signaling Promotes Autoreactive T Cell Infiltration Into Islets in Type 1 Diabetes Model

JCI insight
Medicine
2019English

Regulatory Effects of Programmed Cell Death 4 (PDCD4) Protein in Interferon (IFN)-Stimulated Gene Expression and Generation of Type I IFN Responses

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy